A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Matteo M. Trucco, Christian F. Meyer, Katherine A. Thornton, Preeti Shah, Allen R. Chen, Breelyn A. Wilky, Maria A. Carrera-Haro, Lillian C. Boyer, Margaret F. Ferreira, Umber Shafique, Jonathan D. Powell, David M. Loeb

ABSTRACT

Background: Relapsed and refractory sarcomas continue to have poor survival rates. The cancer stem cell (CSC) theory provides a tractable explanation for the observation that recurrences occur despite dramatic responses to upfront chemotherapy. Preclinical studies demonstrated that inhibition of the mechanistic target of rapamycin (mTOR) sensitizes the CSC population to chemotherapy. Methods: Here we present the results of the Phase II portion of a Phase I/II clinical trial that aimed to overcome the chemoresistance of sarcoma CSC by combining the mTOR inhibitor temsirolimus (20 mg/m2 weekly) with the chemotherapeutic agent liposomal doxorubicin (30 mg/m2 monthly). Results: Fifteen patients with relapsed/refractory sarcoma were evaluable at this recommended Phase 2 dose level. The median progression free survival was 315 days (range 27-799). Response rate, defined as stable disease or better for 60 days, was 53%. Nine of the patients had been previously treated with doxorubicin. Therapy was well tolerated. In a small number of patients, pre- and post- treatment tumor biopsies were available for assessment of ALDH expression as a marker of CSCs and showed a correlation between response and decreased ALDH expression. We also found a correlation between biopsy-proven inhibition of mTOR and response. Conclusions: Our study adds to the literature supporting the addition of mTOR inhibition to chemotherapy agents for the treatment of sarcomas, and proposes that a mechanism by which mTOR inhibition enhances the efficacy of chemotherapy may be through sensitizing the chemoresistant CSC population. Further study, ideally with pre- and post-therapy assessment of ALDH expression in tumor cells, is warranted.Trial registration The trial was registered on clinicaltrials.gov (NCT00949325) on 30 July 2009. http://www.editorialmanager.com/csrj/default.aspx. More... »

PAGES

21

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9

DOI

http://dx.doi.org/10.1186/s13569-018-0107-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106441984

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30410720


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sylvester Comprehensive Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.419791.3", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trucco", 
        "givenName": "Matteo M.", 
        "id": "sg:person.01271362401.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271362401.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meyer", 
        "givenName": "Christian F.", 
        "id": "sg:person.0671233643.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671233643.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Dana Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thornton", 
        "givenName": "Katherine A.", 
        "id": "sg:person.01060373227.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060373227.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Akan Biosciences, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Preeti", 
        "id": "sg:person.01320446625.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320446625.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Allen R.", 
        "id": "sg:person.011331130342.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011331130342.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sylvester Comprehensive Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.419791.3", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilky", 
        "givenName": "Breelyn A.", 
        "id": "sg:person.01100106752.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100106752.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Columbia University", 
          "id": "https://www.grid.ac/institutes/grid.21729.3f", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Columbia University College of Physicians and Surgeons, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carrera-Haro", 
        "givenName": "Maria A.", 
        "id": "sg:person.01213546220.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213546220.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boyer", 
        "givenName": "Lillian C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferreira", 
        "givenName": "Margaret F.", 
        "id": "sg:person.01327774620.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327774620.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shafique", 
        "givenName": "Umber", 
        "id": "sg:person.0652503720.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652503720.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Powell", 
        "givenName": "Jonathan D.", 
        "id": "sg:person.01162106561.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162106561.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Albert Einstein College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.251993.5", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Department of Pediatrics, Albert Einstein College of Medicine, Children\u2019s Hospital at Montefiore, 3411 Wayne Ave., Room 910, 10467, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loeb", 
        "givenName": "David M.", 
        "id": "sg:person.0637477735.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637477735.81"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/ijc.25519", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002828710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2013/480713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004495775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-14-756", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014345450", 
          "https://doi.org/10.1186/1471-2407-14-756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4236/jct.2014.54040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018847250"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.28083", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019909903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.6176", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020789383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0013943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030045270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.6920", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030454788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13577140500287024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030926841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13577140500287024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030926841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.35.6329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043104827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5483/bmbrep.2007.40.6.1069", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045821415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-13-3456", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048644685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25928", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050673398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079022612", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.30589", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084010620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2017.242", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090931195", 
          "https://doi.org/10.1038/onc.2017.242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2016-0474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091330789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.22655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092984548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11523-017-0539-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092996951", 
          "https://doi.org/10.1007/s11523-017-0539-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "Background: Relapsed and refractory sarcomas continue to have poor survival rates. The cancer stem cell (CSC) theory provides a tractable explanation for the observation that recurrences occur despite dramatic responses to upfront chemotherapy. Preclinical studies demonstrated that inhibition of the mechanistic target of rapamycin (mTOR) sensitizes the CSC population to chemotherapy.\nMethods: Here we present the results of the Phase II portion of a Phase I/II clinical trial that aimed to overcome the chemoresistance of sarcoma CSC by combining the mTOR inhibitor temsirolimus (20\u00a0mg/m2 weekly) with the chemotherapeutic agent liposomal doxorubicin (30\u00a0mg/m2 monthly).\nResults: Fifteen patients with relapsed/refractory sarcoma were evaluable at this recommended Phase 2 dose level. The median progression free survival was 315\u00a0days (range 27-799). Response rate, defined as stable disease or better for 60\u00a0days, was 53%. Nine of the patients had been previously treated with doxorubicin. Therapy was well tolerated. In a small number of patients, pre- and post- treatment tumor biopsies were available for assessment of ALDH expression as a marker of CSCs and showed a correlation between response and decreased ALDH expression. We also found a correlation between biopsy-proven inhibition of mTOR and response.\nConclusions: Our study adds to the literature supporting the addition of mTOR inhibition to chemotherapy agents for the treatment of sarcomas, and proposes that a mechanism by which mTOR inhibition enhances the efficacy of chemotherapy may be through sensitizing the chemoresistant CSC population. Further study, ideally with pre- and post-therapy assessment of ALDH expression in tumor cells, is warranted.Trial registration The trial was registered on clinicaltrials.gov (NCT00949325) on 30 July 2009. http://www.editorialmanager.com/csrj/default.aspx.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13569-018-0107-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2458242", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1046367", 
        "issn": [
          "2045-3329"
        ], 
        "name": "Clinical Sarcoma Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas", 
    "pagination": "21", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1febf2658cc89bda2143eb9aae0b4720d4cf534096a9296c78c62ef9775a42be"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30410720"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101577890"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13569-018-0107-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106441984"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13569-018-0107-9", 
      "https://app.dimensions.ai/details/publication/pub.1106441984"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78970_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13569-018-0107-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'


 

This table displays all metadata directly associated to this object as RDF triples.

224 TRIPLES      21 PREDICATES      48 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13569-018-0107-9 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N20317bec60114ea99b1bd5bc0c5455bb
4 schema:citation sg:pub.10.1007/s11523-017-0539-9
5 sg:pub.10.1038/onc.2017.242
6 sg:pub.10.1186/1471-2407-14-756
7 https://app.dimensions.ai/details/publication/pub.1079022612
8 https://doi.org/10.1002/cncr.25928
9 https://doi.org/10.1002/cncr.30589
10 https://doi.org/10.1002/ijc.25519
11 https://doi.org/10.1002/ijc.28083
12 https://doi.org/10.1080/13577140500287024
13 https://doi.org/10.1155/2013/480713
14 https://doi.org/10.1158/0008-5472.can-13-3456
15 https://doi.org/10.1200/jco.2011.35.6329
16 https://doi.org/10.1371/journal.pone.0013943
17 https://doi.org/10.1634/theoncologist.2016-0474
18 https://doi.org/10.18632/oncotarget.22655
19 https://doi.org/10.18632/oncotarget.6176
20 https://doi.org/10.18632/oncotarget.6920
21 https://doi.org/10.4236/jct.2014.54040
22 https://doi.org/10.5483/bmbrep.2007.40.6.1069
23 schema:datePublished 2018-12
24 schema:datePublishedReg 2018-12-01
25 schema:description Background: Relapsed and refractory sarcomas continue to have poor survival rates. The cancer stem cell (CSC) theory provides a tractable explanation for the observation that recurrences occur despite dramatic responses to upfront chemotherapy. Preclinical studies demonstrated that inhibition of the mechanistic target of rapamycin (mTOR) sensitizes the CSC population to chemotherapy. Methods: Here we present the results of the Phase II portion of a Phase I/II clinical trial that aimed to overcome the chemoresistance of sarcoma CSC by combining the mTOR inhibitor temsirolimus (20 mg/m2 weekly) with the chemotherapeutic agent liposomal doxorubicin (30 mg/m2 monthly). Results: Fifteen patients with relapsed/refractory sarcoma were evaluable at this recommended Phase 2 dose level. The median progression free survival was 315 days (range 27-799). Response rate, defined as stable disease or better for 60 days, was 53%. Nine of the patients had been previously treated with doxorubicin. Therapy was well tolerated. In a small number of patients, pre- and post- treatment tumor biopsies were available for assessment of ALDH expression as a marker of CSCs and showed a correlation between response and decreased ALDH expression. We also found a correlation between biopsy-proven inhibition of mTOR and response. Conclusions: Our study adds to the literature supporting the addition of mTOR inhibition to chemotherapy agents for the treatment of sarcomas, and proposes that a mechanism by which mTOR inhibition enhances the efficacy of chemotherapy may be through sensitizing the chemoresistant CSC population. Further study, ideally with pre- and post-therapy assessment of ALDH expression in tumor cells, is warranted.Trial registration The trial was registered on clinicaltrials.gov (NCT00949325) on 30 July 2009. http://www.editorialmanager.com/csrj/default.aspx.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf Ne2d8b7fc07364fceb63699096765e86a
30 Nf457c0ee0d324c89850cf76f81d8b8eb
31 sg:journal.1046367
32 schema:name A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
33 schema:pagination 21
34 schema:productId N0ad5514eafd3496f84d99eb4af495de3
35 N6c82384376d7412287a29165376f6242
36 N7cfcf38e35ce4590bf5c78cd645fbba9
37 N9bdc68b21d3b4ce098445fb673f3b537
38 Nd5dc3d5afc9a4b5bab72e9d1a0918cda
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106441984
40 https://doi.org/10.1186/s13569-018-0107-9
41 schema:sdDatePublished 2019-04-11T13:20
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N80a7251707214f7cba80bb90e554711d
44 schema:url https://link.springer.com/10.1186%2Fs13569-018-0107-9
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N0ad5514eafd3496f84d99eb4af495de3 schema:name dimensions_id
49 schema:value pub.1106441984
50 rdf:type schema:PropertyValue
51 N1a7b944db1db47e799171246012f5587 rdf:first sg:person.011331130342.94
52 rdf:rest N8162268bb2e048c09289a5350253ff5e
53 N20317bec60114ea99b1bd5bc0c5455bb rdf:first sg:person.01271362401.35
54 rdf:rest Ne8ad7db5e67140329a910394d1d48cf8
55 N31e65813652e4788b5f44cf990fb978a rdf:first sg:person.01327774620.47
56 rdf:rest N66324b695d4144bdb472a6ebf8239553
57 N61abd4dc492e4c8384e5d233da0110f5 rdf:first sg:person.01162106561.71
58 rdf:rest N843df319a2d34a60baf20765abb268ef
59 N66324b695d4144bdb472a6ebf8239553 rdf:first sg:person.0652503720.97
60 rdf:rest N61abd4dc492e4c8384e5d233da0110f5
61 N666eb1b863de4ae48069fcfb20778bb2 rdf:first Ne481fe56f64848c48b2e1303c2b36be7
62 rdf:rest N31e65813652e4788b5f44cf990fb978a
63 N6c82384376d7412287a29165376f6242 schema:name nlm_unique_id
64 schema:value 101577890
65 rdf:type schema:PropertyValue
66 N7cfcf38e35ce4590bf5c78cd645fbba9 schema:name doi
67 schema:value 10.1186/s13569-018-0107-9
68 rdf:type schema:PropertyValue
69 N80a7251707214f7cba80bb90e554711d schema:name Springer Nature - SN SciGraph project
70 rdf:type schema:Organization
71 N8162268bb2e048c09289a5350253ff5e rdf:first sg:person.01100106752.21
72 rdf:rest Nb32c8a81b01c471981e535ec2e65b76f
73 N843df319a2d34a60baf20765abb268ef rdf:first sg:person.0637477735.81
74 rdf:rest rdf:nil
75 N99e9c2fd2b55495d8c0b9e59e139ffbc rdf:first sg:person.01060373227.64
76 rdf:rest Nab0bc563cc7d40a0b2cb01d0f622db09
77 N9bdc68b21d3b4ce098445fb673f3b537 schema:name pubmed_id
78 schema:value 30410720
79 rdf:type schema:PropertyValue
80 Nab0bc563cc7d40a0b2cb01d0f622db09 rdf:first sg:person.01320446625.89
81 rdf:rest N1a7b944db1db47e799171246012f5587
82 Nb32c8a81b01c471981e535ec2e65b76f rdf:first sg:person.01213546220.84
83 rdf:rest N666eb1b863de4ae48069fcfb20778bb2
84 Nd5dc3d5afc9a4b5bab72e9d1a0918cda schema:name readcube_id
85 schema:value 1febf2658cc89bda2143eb9aae0b4720d4cf534096a9296c78c62ef9775a42be
86 rdf:type schema:PropertyValue
87 Ne2d8b7fc07364fceb63699096765e86a schema:volumeNumber 8
88 rdf:type schema:PublicationVolume
89 Ne481fe56f64848c48b2e1303c2b36be7 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
90 schema:familyName Boyer
91 schema:givenName Lillian C.
92 rdf:type schema:Person
93 Ne8ad7db5e67140329a910394d1d48cf8 rdf:first sg:person.0671233643.18
94 rdf:rest N99e9c2fd2b55495d8c0b9e59e139ffbc
95 Nf457c0ee0d324c89850cf76f81d8b8eb schema:issueNumber 1
96 rdf:type schema:PublicationIssue
97 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
98 schema:name Medical and Health Sciences
99 rdf:type schema:DefinedTerm
100 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
101 schema:name Oncology and Carcinogenesis
102 rdf:type schema:DefinedTerm
103 sg:grant.2458242 http://pending.schema.org/fundedItem sg:pub.10.1186/s13569-018-0107-9
104 rdf:type schema:MonetaryGrant
105 sg:journal.1046367 schema:issn 2045-3329
106 schema:name Clinical Sarcoma Research
107 rdf:type schema:Periodical
108 sg:person.01060373227.64 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
109 schema:familyName Thornton
110 schema:givenName Katherine A.
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060373227.64
112 rdf:type schema:Person
113 sg:person.01100106752.21 schema:affiliation https://www.grid.ac/institutes/grid.419791.3
114 schema:familyName Wilky
115 schema:givenName Breelyn A.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100106752.21
117 rdf:type schema:Person
118 sg:person.011331130342.94 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
119 schema:familyName Chen
120 schema:givenName Allen R.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011331130342.94
122 rdf:type schema:Person
123 sg:person.01162106561.71 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
124 schema:familyName Powell
125 schema:givenName Jonathan D.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162106561.71
127 rdf:type schema:Person
128 sg:person.01213546220.84 schema:affiliation https://www.grid.ac/institutes/grid.21729.3f
129 schema:familyName Carrera-Haro
130 schema:givenName Maria A.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213546220.84
132 rdf:type schema:Person
133 sg:person.01271362401.35 schema:affiliation https://www.grid.ac/institutes/grid.419791.3
134 schema:familyName Trucco
135 schema:givenName Matteo M.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271362401.35
137 rdf:type schema:Person
138 sg:person.01320446625.89 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
139 schema:familyName Shah
140 schema:givenName Preeti
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320446625.89
142 rdf:type schema:Person
143 sg:person.01327774620.47 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
144 schema:familyName Ferreira
145 schema:givenName Margaret F.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327774620.47
147 rdf:type schema:Person
148 sg:person.0637477735.81 schema:affiliation https://www.grid.ac/institutes/grid.251993.5
149 schema:familyName Loeb
150 schema:givenName David M.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637477735.81
152 rdf:type schema:Person
153 sg:person.0652503720.97 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
154 schema:familyName Shafique
155 schema:givenName Umber
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652503720.97
157 rdf:type schema:Person
158 sg:person.0671233643.18 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
159 schema:familyName Meyer
160 schema:givenName Christian F.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671233643.18
162 rdf:type schema:Person
163 sg:pub.10.1007/s11523-017-0539-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092996951
164 https://doi.org/10.1007/s11523-017-0539-9
165 rdf:type schema:CreativeWork
166 sg:pub.10.1038/onc.2017.242 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090931195
167 https://doi.org/10.1038/onc.2017.242
168 rdf:type schema:CreativeWork
169 sg:pub.10.1186/1471-2407-14-756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014345450
170 https://doi.org/10.1186/1471-2407-14-756
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1079022612 schema:CreativeWork
173 https://doi.org/10.1002/cncr.25928 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050673398
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1002/cncr.30589 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084010620
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1002/ijc.25519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002828710
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1002/ijc.28083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019909903
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1080/13577140500287024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030926841
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1155/2013/480713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004495775
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1158/0008-5472.can-13-3456 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048644685
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1200/jco.2011.35.6329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043104827
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1371/journal.pone.0013943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030045270
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1634/theoncologist.2016-0474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091330789
192 rdf:type schema:CreativeWork
193 https://doi.org/10.18632/oncotarget.22655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092984548
194 rdf:type schema:CreativeWork
195 https://doi.org/10.18632/oncotarget.6176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020789383
196 rdf:type schema:CreativeWork
197 https://doi.org/10.18632/oncotarget.6920 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030454788
198 rdf:type schema:CreativeWork
199 https://doi.org/10.4236/jct.2014.54040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018847250
200 rdf:type schema:CreativeWork
201 https://doi.org/10.5483/bmbrep.2007.40.6.1069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045821415
202 rdf:type schema:CreativeWork
203 https://www.grid.ac/institutes/grid.21107.35 schema:alternateName Johns Hopkins University
204 schema:name Akan Biosciences, Gaithersburg, MD, USA
205 Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
206 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
207 rdf:type schema:Organization
208 https://www.grid.ac/institutes/grid.21729.3f schema:alternateName Columbia University
209 schema:name Columbia University College of Physicians and Surgeons, New York, NY, USA
210 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
211 rdf:type schema:Organization
212 https://www.grid.ac/institutes/grid.251993.5 schema:alternateName Albert Einstein College of Medicine
213 schema:name Department of Pediatrics, Albert Einstein College of Medicine, Children’s Hospital at Montefiore, 3411 Wayne Ave., Room 910, 10467, Bronx, NY, USA
214 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.419791.3 schema:alternateName Sylvester Comprehensive Cancer Center
217 schema:name Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
218 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
219 Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
220 rdf:type schema:Organization
221 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
222 schema:name Dana Farber Cancer Institute, Boston, MA, USA
223 Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
224 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...